Ohta, Shigeru

Drug-Metabolizing Ability of Molybdenum Hydroxylases

Kitamura, S., Sugihara, K., & Ohta, S. (2006) · Drug Metabolism and Pharmacokinetics

Pharmacogenetics and Drug MetabolismMetal-Catalyzed Oxygenation Mechanisms

Cited by 216

Comparison of Drug Metabolism and Its Related Hepatotoxic Effects in HepaRG, Cryopreserved Human Hepatocytes, and HepG2 Cell Cultures

Yokoyama, Y., Sasaki, Y., Terasaki, N., Kawataki, T., Takekawa, K., Iwase, Y., Shimizu, T., Sanoh, S., & Ohta, S. (2018) · Biological and Pharmaceutical Bulletin

Drug-Induced Hepatotoxicity and ProtectionPharmacogenetics and Drug Metabolism

Cited by 160

Perfluorooctane Sulfonate Induces Neuronal Vulnerability by Decreasing GluR2 Expression

Ishida, K., Tsuyama, Y., Sanoh, S., Ohta, S., & Kotake, Y. (2017) · Archives of Toxicology

Per- and polyfluoroalkyl substances researchToxic Organic Pollutants Impact

Cited by 27

Somatic cell mutation frequency at the HPRT, T-cell antigen receptor and glycophorin A loci in Cockayne syndrome

Lin, Y.-W., Kubota, M., Hirota, H., Furusho, K., Tomiwa, K., Ochi, J., Kasahara, Y., Sasaki, H., & Ohta, S. (1995) · Mutation Research/DNA Repair

DNA Repair MechanismsCarcinogens and Genotoxicity Assessment

Cited by 11